Dr. Lee was born in Shanghai, China, and received his college and medical training in the United States. He is fluent in English and three Chinese dialects. He graduated with chemistry departmental honors from Harvey Mudd College. He was appointed president of AOA society at UCLA School of Medicine. He underwent internal medicine residency and gastroenterology fellowship training at Cedars Sinai Medical Center.
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
Patients who have hereditary colon cancer syndromes usually
have no symptoms and are unaware that they have colon polyps or early colon
cancers. They usually will develop colon cancers early in life (often before
ages 40-50). Therefore, to prevent colon cancers in patients with hereditary
colon cancer syndromes, colon screening must begin early. For example, patients
with FAP should have annual flexible sigmoidoscopies starting at age 12,
patients with AFAP should have annual colonoscopies starting at age 25, and
patients with HNPCC should have colonoscopies beginning at age 25 (or 10 years
younger than the earliest colon cancer diagnosed in the family, whichever is
earlier). The current screening recommendations for the general population
(fecal occult blood testing, flexible sigmoidoscopy, and colonoscopy beginning at ages 40-50) are
inadequate for most patients with hereditary colon cancer syndromes.
Genetic counseling and testing are important to identify
patients and family members with hereditary colon cancer syndromes so that
screening with flexible sigmoidoscopies and colonoscopies can begin early and,
if necessary, the colon can be removed surgically to prevent colon cancer.
Moreover, depending on which hereditary colon cancer syndrome is present, early
screening for other types of cancer such as ovarian, uterine, stomach, ureter, and thyroid may be